Clinical Trial Results

Condition: Multiple Sclerosis Location: Oklahoma City, Oklahoma 6 trials found

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

PHASE2INTERVENTIONAL Boston, Massachusetts +4 more

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

Skeletal Muscle Aging and Responsiveness in Aged People With MS

NAINTERVENTIONAL Oklahoma City, Oklahoma

Early Versus Delayed Start of Ocrevus Zunovo for Relapsing Multiple Sclerosis

N/AOBSERVATIONAL Oklahoma City, Oklahoma

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more